Alexion Pharmaceuticals

Alexion Pharmaceuticals is a biopharmaceutical company headquartered in Boston, Massachusetts, founded in 1992 and acquired by AstraZeneca in 2021. Alexion specializes in therapies for rare and ultra-rare diseases, with leading products luding Soliris, Ultomiris, and Strensiq. The company maintains a global presence, serving patients in more than 50 countries and complying with FDA, EMA, and international health agency standards. Alexion’s 2025 annual revenue is estimated at $6.1 billion, supporting its leadership in complement and metabolic therapeutics.​

Alexion Pharmaceuticals Overview

  • Company: Alexion Pharmaceuticals
  • Industry: Pharmaceuticals
  • Employees: 1,001-5,000
  • Location: 121 Seaport Blvd, Boston, MA 02210-2050, US
  • Founded: 1992

Alexion Pharmaceuticals Certifications and Compliance

Through Panorays' Attack Surface Assessments, you can view all identified published certifications, providing a clearer and more accurate understanding of your compliance status

Alexion Pharmaceuticals Cyber Related News

Access business-specific cyber news from diverse sources, all categorized and consolidated in one place, ensuring clear visibility into cyber events and incidents relevant to your organization.
#0
No relevant cyber news available at this time.

Alexion Pharmaceuticals External Attack Surface Geolocation Map

Gain detailed insights into the location of your assets through our comprehensive external assessments.

Alexion Pharmaceuticals Supply Chain Discovery

Supply Chain Discovery identifies Nth-party connections to your company, maps their relationships, and continuously monitors them for cyber threats. The following graph segments detected third parties according to their Cyber Posture Rating.

Alexion Pharmaceuticals Cyber Posture Rating

Alexion Pharmaceuticals security rating reflects the analysis of its external attack surface. A higher rating indicates a stronger security posture. Begin a free trial to receive a comprehensive risk assessment for Alexion Pharmaceuticals.
Is this your company? Claim your security score now.
NA

Alexion Pharmaceuticals Category Breakdown

Human

Employee NA
Security Team NA
Social Posture NA
Dynamics NA

Application

Techs NA
Application Security NA
Domain Attacks NA
Exposed Services NA

IT

DNS NA
Mail Server NA
Asset Reputation NA
Web Server NA
TLS NA
Cloud NA
Endpoint NA
Forrester logo

Panorays is a Leader

“Panorays stands out with one of the most ambitious roadmaps and innovation driven approaches to agentic AI in this evaluation…”

Get the Report

Panorays is a Leader - in The Forrester Wave in Cybersecurity Risk Ratings Platforms, 2026

Is your organization secure?

Discover critical risks and vulnerabilities in your supply chain with our comprehensive report.